{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:09:38Z","timestamp":1766182178672,"version":"3.48.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":42,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008368","name":"Gigtforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008368","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ero.2025.11.009","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T22:11:55Z","timestamp":1765059115000},"page":"452-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes of patients with diffuse large B-cell lymphoma and concomitant rheumatoid arthritis: a nationwide Danish register-based cohort study"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0255-8310","authenticated-orcid":false,"given":"Bergur","family":"Magnussen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene Wohlfart","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salome","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarec Christoffer","family":"El-Galaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lasse Hjort","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"Mellemkj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikkel","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasmus","family":"Westermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ero.2025.11.009_bib0001","first-page":"5","article-title":"Epidemiology of non-Hodgkin\u2019s lymphoma","volume":"9","author":"Thandra","year":"2021","journal-title":"Med Sci (Basel)"},{"issue":"5","key":"10.1016\/j.ero.2025.11.009_bib0002","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/0961203321990106","article-title":"Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: a Danish nationwide cohort study","volume":"30","author":"Westermann","year":"2021","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.ero.2025.11.009_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002776","article-title":"Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study","volume":"8","author":"Cordtz","year":"2022","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.ero.2025.11.009_bib0004","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/ijc.24287","article-title":"Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies","volume":"125","author":"Anderson","year":"2009","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.ero.2025.11.009_bib0005","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstr\u00f6m Smedby","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ero.2025.11.009_bib0006","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/art.11144","article-title":"Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma","volume":"48","author":"Baecklund","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ero.2025.11.009_bib0007","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/rheumatology\/keaa330","article-title":"Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype","volume":"60","author":"Hellgren","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ero.2025.11.009_bib0008","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/art.40017","article-title":"Rheumatoid arthritis and risk of malignant lymphoma: is the risk still increased?","volume":"69","author":"Hellgren","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.ero.2025.11.009_bib0009","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/hon.2525","article-title":"Rheumatoid arthritis and lymphoma: incidence, pathogenesis, biology, and outcome","volume":"36","author":"Klein","year":"2018","journal-title":"Hematol Oncol"},{"issue":"1","key":"10.1016\/j.ero.2025.11.009_bib0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.ero.2025.11.009_bib0011","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ero.2025.11.009_bib0012","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V99.11.3909","article-title":"Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France","volume":"99","author":"Mariette","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ero.2025.11.009_bib0013","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0046-8177(94)90295-X","article-title":"Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression","volume":"25","author":"Kamel","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ero.2025.11.009_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2023.03.003","article-title":"Prognostic factors for diffuse large B-cell lymphoma: clinical and biological factors in the rituximab era","volume":"122","author":"Liang","year":"2023","journal-title":"Exp Hematol"},{"issue":"8","key":"10.1016\/j.ero.2025.11.009_bib0015","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/rheumatology\/ker143","article-title":"Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer","volume":"50","author":"Ji","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.ero.2025.11.009_bib0016","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.clml.2017.11.009","article-title":"Characterizing autoimmune disease-associated diffuse large B-cell lymphoma in a SEER\u2013Medicare cohort","volume":"18","author":"Koff","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"10.1016\/j.ero.2025.11.009_bib0017","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/hon.2498","article-title":"Presence of autoimmune disease affects not only risk but also survival in patients with B-cell non-Hodgkin lymphoma","volume":"36","author":"Kleinstern","year":"2018","journal-title":"Hematol Oncol"},{"issue":"10","key":"10.1016\/j.ero.2025.11.009_bib0018","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1200\/JCO.2005.04.6227","article-title":"Prospective study of survival outcomes in non-Hodgkin\u2019s lymphoma patients with rheumatoid arthritis","volume":"24","author":"Mikuls","year":"2006","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ero.2025.11.009_bib0019","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ero.2025.11.009_bib0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish civil registration system","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.ero.2025.11.009_bib0021","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2147\/CLEP.S99470","article-title":"Danish national lymphoma registry","volume":"8","author":"Arboe","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.ero.2025.11.009_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157999","article-title":"The Danish National Lymphoma Registry: coverage and data quality","volume":"11","author":"Arboe","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ero.2025.11.009_bib0023","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish pathology register","volume":"39","author":"Bjerregaard","year":"2011","journal-title":"Scand J Public Health"},{"issue":"5","key":"10.1016\/j.ero.2025.11.009_bib0024","first-page":"S205","article-title":"DANBIO: a nationwide registry of biological therapies in Denmark","volume":"23","author":"Hetland","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ero.2025.11.009_bib0025","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2147\/CLEP.S99490","article-title":"The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO","volume":"8","author":"Ibfelt","year":"2016","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ero.2025.11.009_bib0026","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/CLEP.S141438","article-title":"Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry","volume":"9","author":"Ibfelt","year":"2017","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ero.2025.11.009_bib0027","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ero.2025.11.009_bib0028","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1403494811401482","article-title":"The Danish national patient register","volume":"39","author":"Lynge","year":"2011","journal-title":"Scand J Public Health"},{"issue":"1","key":"10.1016\/j.ero.2025.11.009_bib0029","first-page":"9","article-title":"Validity of the coding for intensive care admission, mechanical ventilation, and acute dialysis in the Danish national patient registry: a short report","volume":"5","author":"Blichert-Hansen","year":"2013","journal-title":"Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.ero.2025.11.009_bib0030","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10985-010-9157-x","article-title":"Models and estimation for systems with recurrent events and usage processes","volume":"16","author":"Lawless","year":"2010","journal-title":"Lifetime Data Anal"},{"issue":"10","key":"10.1016\/j.ero.2025.11.009_bib0031","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00296-015-3271-8","article-title":"Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis","volume":"35","author":"Katchamart","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ero.2025.11.009_bib0032","article-title":"Patients with seronegative rheumatoid arthritis have a different phenotype than seropositive patients: a clinical and ultrasound study","volume":"9","author":"Carbonell-Bobadilla","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ero.2025.11.009_bib0033","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/annrheumdis-2024-eular.2163","article-title":"OP0162 The temporal mortality trend in seropositive and seronegative rheumatoid arthritis - a Danish population-based cohort study","volume":"83","author":"Lauritzen","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ero.2025.11.009_bib0034","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1200\/JCO.1996.14.6.1943","article-title":"Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases","volume":"14","author":"Salloum","year":"1996","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ero.2025.11.009_bib0035","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0049-0172(97)80023-6","article-title":"Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment","volume":"26","author":"Georgescu","year":"1997","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ero.2025.11.009_bib0036","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/annrheumdis-2017-eular.4683","article-title":"THU0209 Lymphocyte subsets in biopsy specimen are associated with spontaneous regression of lymphoproliferative disorders in rheumatoid arthritis patients treated with methotrexate","volume":"76","author":"Kameda","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ero.2025.11.009_bib0037","first-page":"1095","article-title":"Non-Hodgkin\u2019s lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate","volume":"23","author":"Usman","year":"1996","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.ero.2025.11.009_bib0038","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/art.22277","article-title":"Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.ero.2025.11.009_bib0039","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/acr.22713","article-title":"Prevalence of renal impairment in patients with rheumatoid arthritis: results from a cross-sectional multicenter study","volume":"68","author":"Couderc","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"10.1016\/j.ero.2025.11.009_bib0040","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1007\/s10067-017-3804-5","article-title":"Prevalence of and factors associated with renal dysfunction in rheumatoid arthritis patients: a cross-sectional study in community hospitals","volume":"36","author":"Mori","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.ero.2025.11.009_bib0041","doi-asserted-by":"crossref","first-page":"232","DOI":"10.12968\/bjcn.2022.27.5.232","article-title":"Central Lancashire Online Knowledge (CLoK) The prevalence of comorbidity in rheumatoid arthritis: a systematic review and meta-analysis: a systematic review","volume":"27","author":"Hill","year":"2022","journal-title":"Br J Community Nurs"},{"key":"10.1016\/j.ero.2025.11.009_bib0042","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jclinepi.2021.08.028","article-title":"Causal analyses of existing databases: no power calculations required","volume":"144","author":"Hern\u00e1n","year":"2022","journal-title":"J Clin Epidemiol"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125001090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125001090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T22:02:42Z","timestamp":1766181762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708125001090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S3050708125001090"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2025.11.009","relation":{},"ISSN":["3050-7081"],"issn-type":[{"type":"print","value":"3050-7081"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of patients with diffuse large B-cell lymphoma and concomitant rheumatoid arthritis: a nationwide Danish register-based cohort study","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}